Cryo Rib Fracture Study

NCT ID: NCT06347874

Last Updated: 2025-02-17

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

PHASE4

Total Enrollment

48 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-01-10

Study Completion Date

2027-07-20

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to determine if patients with rib fractures who undergo cryoablation of the intercostal nerves have improved pain control 7 days from procedure when compared to those who have a ESP catheter.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Rib Fractures

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

This is a randomized prospective controlled trial. This will be single blinded trial. The individual doing the outcome assessments will be blinded. Randomization will be 1:1.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors
The individual doing the outcome assessments will be blinded.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cryoablation

Participants with rib fracture randomized to Cryoablation.

Group Type EXPERIMENTAL

Cryoablation

Intervention Type DRUG

an injection of 1ml of 1% lidocaine per rib and ultrasound guided cryoablation of the intercostal nerves

ESP catheter

Participants with rib fracture randomized to ESP Catheter.

Group Type ACTIVE_COMPARATOR

ESP Catheter

Intervention Type DRUG

an ultrasound guided erector spinae plane catheter with initial bolus of 30 mL of 0.25% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour via programmed intermittent bolus.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cryoablation

an injection of 1ml of 1% lidocaine per rib and ultrasound guided cryoablation of the intercostal nerves

Intervention Type DRUG

ESP Catheter

an ultrasound guided erector spinae plane catheter with initial bolus of 30 mL of 0.25% bupivacaine followed by infusion of 0.2% ropivacaine at 10 mL per hour via programmed intermittent bolus.

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients who are over 18 who have more than one ribs fractured.

Exclusion Criteria

* Patients who have an exclusion to regional anesthesia.
* Patients who are pregnant via self-report or pregnancy test if they take one.
* Non-English speakers
* Patients who have cold urticaria
* Patients with bilateral fractures
* Patients currently intubated
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Minnesota

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Neil Hanson

Role: PRINCIPAL_INVESTIGATOR

University of Minnesota

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Minnesota

Minneapolis, Minnesota, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Candace Nelson

Role: CONTACT

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Allicia Bulleri

Role: primary

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ANES-2024-32820

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Cryo Nerve Block Trial
NCT06861387 NOT_YET_RECRUITING NA
Minimally Invasive Esophagectomy Pain Control Trial
NCT05906134 RECRUITING PHASE1/PHASE2